Cumberland Pharmaceuticals, Inc. (CPIX)
6.62
-0.17
(-2.50%)
USD |
NASDAQ |
Sep 08, 16:00
6.80
+0.18
(+2.72%)
Pre-Market: 08:08
Cumberland Pharmaceuticals Debt to Equity Ratio : 0.2703 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2703 |
| March 31, 2026 | 0.4654 |
| December 31, 2025 | 0.4092 |
| September 30, 2025 | 0.392 |
| June 30, 2025 | 0.3695 |
| March 31, 2025 | 0.3643 |
| December 31, 2024 | 0.9002 |
| September 30, 2024 | 0.8669 |
| June 30, 2024 | 0.8186 |
| March 31, 2024 | 0.7875 |
| December 31, 2023 | 0.6225 |
| September 30, 2023 | 0.5181 |
| June 30, 2023 | 0.5099 |
| March 31, 2023 | 0.5715 |
| December 31, 2022 | 0.5779 |
| September 30, 2022 | 0.4625 |
| June 30, 2022 | 0.4944 |
| March 31, 2022 | 0.5068 |
| December 31, 2021 | 0.3751 |
| September 30, 2021 | 0.3486 |
| June 30, 2021 | 0.3249 |
| March 31, 2021 | 0.358 |
| December 31, 2020 | 0.3634 |
| September 30, 2020 | 0.403 |
| June 30, 2020 | 0.4032 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4264 |
| December 31, 2019 | 0.4205 |
| September 30, 2019 | 0.4487 |
| June 30, 2019 | 0.4329 |
| March 31, 2019 | 0.4263 |
| December 31, 2018 | 0.3581 |
| September 30, 2018 | 0.2062 |
| June 30, 2018 | 0.2003 |
| March 31, 2018 | 0.1964 |
| December 31, 2017 | 0.1528 |
| September 30, 2017 | 0.1229 |
| June 30, 2017 | 0.1005 |
| March 31, 2017 | 0.0567 |
| December 31, 2016 | 0.056 |
| September 30, 2016 | 0.0496 |
| June 30, 2016 | 0.047 |
| March 31, 2016 | 0.0225 |
| December 31, 2015 | 0.0221 |
| September 30, 2015 | 0.0219 |
| June 30, 2015 | 0.0216 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 62.88M |
| Total Liabilities (Quarterly) | 45.77M |
| Shareholders Equity (Quarterly) | 17.44M |
| Current Ratio | 0.9559 |
| Net Debt Paydown Yield | 1.18% |